Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| endothelial cell | 28 studies | 31% ± 9% | |
| capillary endothelial cell | 14 studies | 26% ± 7% | |
| endothelial cell of artery | 9 studies | 24% ± 6% | |
| endothelial cell of vascular tree | 8 studies | 25% ± 11% | |
| type I pneumocyte | 7 studies | 30% ± 7% | |
| type II pneumocyte | 7 studies | 39% ± 12% | |
| basal cell | 7 studies | 25% ± 10% | |
| mucus secreting cell | 5 studies | 31% ± 10% | |
| vein endothelial cell | 5 studies | 25% ± 11% | |
| ciliated cell | 5 studies | 28% ± 8% | |
| club cell | 5 studies | 38% ± 13% | |
| glomerular endothelial cell | 4 studies | 53% ± 12% | |
| epithelial cell | 4 studies | 41% ± 10% | |
| fibroblast | 4 studies | 26% ± 10% | |
| hepatocyte | 4 studies | 46% ± 13% | |
| goblet cell | 4 studies | 45% ± 26% | |
| pancreatic A cell | 3 studies | 35% ± 5% | |
| type B pancreatic cell | 3 studies | 43% ± 17% | |
| pro-B cell | 3 studies | 45% ± 9% | |
| respiratory goblet cell | 3 studies | 38% ± 20% | |
| interneuron | 3 studies | 17% ± 1% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| liver | 100% | 1001.73 | 226 / 226 | 99% | 58.05 | 402 / 406 |
| pancreas | 100% | 1031.59 | 328 / 328 | 99% | 34.20 | 176 / 178 |
| thymus | 100% | 681.83 | 652 / 653 | 99% | 55.43 | 598 / 605 |
| lung | 100% | 889.95 | 578 / 578 | 98% | 36.66 | 1131 / 1155 |
| prostate | 99% | 413.79 | 243 / 245 | 98% | 37.11 | 491 / 502 |
| stomach | 96% | 496.55 | 343 / 359 | 99% | 46.57 | 284 / 286 |
| breast | 100% | 759.02 | 459 / 459 | 95% | 37.36 | 1060 / 1118 |
| esophagus | 90% | 149.26 | 1307 / 1445 | 93% | 32.36 | 171 / 183 |
| bladder | 95% | 217.33 | 20 / 21 | 88% | 29.36 | 444 / 504 |
| kidney | 100% | 413.91 | 89 / 89 | 82% | 12.80 | 738 / 901 |
| intestine | 79% | 180.89 | 763 / 966 | 99% | 45.08 | 520 / 527 |
| uterus | 98% | 206.58 | 166 / 170 | 71% | 18.12 | 327 / 459 |
| adrenal gland | 100% | 588.76 | 258 / 258 | 53% | 16.77 | 123 / 230 |
| skin | 90% | 313.92 | 1622 / 1809 | 51% | 10.96 | 242 / 472 |
| ovary | 24% | 39.02 | 44 / 180 | 100% | 53.14 | 430 / 430 |
| brain | 78% | 134.11 | 2068 / 2642 | 36% | 4.58 | 256 / 705 |
| adipose | 100% | 654.77 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| heart | 100% | 303.19 | 858 / 861 | 0% | 0 | 0 / 0 |
| blood vessel | 77% | 141.19 | 1024 / 1335 | 0% | 0 | 0 / 0 |
| muscle | 70% | 96.30 | 564 / 803 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 58% | 8.80 | 26 / 45 |
| lymph node | 0% | 0 | 0 / 0 | 41% | 4.34 | 12 / 29 |
| peripheral blood | 27% | 34.50 | 248 / 929 | 0% | 0 | 0 / 0 |
| spleen | 24% | 25.86 | 58 / 241 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 9% | 0.87 | 7 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0007165 | Biological process | signal transduction |
| GO_0006935 | Biological process | chemotaxis |
| GO_0042552 | Biological process | myelination |
| GO_0005615 | Cellular component | extracellular space |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0016020 | Cellular component | membrane |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0005515 | Molecular function | protein binding |
| GO_0019911 | Molecular function | structural constituent of myelin sheath |
| GO_0005125 | Molecular function | cytokine activity |
| Gene name | CMTM8 |
| Protein name | CKLF-like MARVEL transmembrane domain-containing protein 8 (Chemokine-like factor superfamily member 8) |
| Synonyms | CKLFSF8 |
| Description | |
| Accessions | ENST00000307526.4 [Q8IZV2-1] Q8IZV2 ENST00000458535.6 [Q8IZV2-2] |